PTX 7.32% 4.4¢ prescient therapeutics limited

Ann: AGM Presentation, page-3

  1. 250 Posts.
    lightbulb Created with Sketch. 84
    From Page 46 of the presentation :
    • Clarification of next steps for PTX-100’s clinical development in TCL
    • FDA is currently reviewing accelerated approval processes

    Hopefully the review will be positive. Interested in SYC comments at his next briefing.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.003(7.32%)
Mkt cap ! $35.43M
Open High Low Value Volume
4.1¢ 4.4¢ 4.0¢ $20.95K 507.0K

Buyers (Bids)

No. Vol. Price($)
8 216927 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 238807 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.